Skip to main content
. 2020 May-Jun;35(3):291–298. doi: 10.21470/1678-9741-2019-0112

Table 1.

Baseline characteristics of the groups.

Characteristics Lidocaine group (n=30) Control group (n=30) P-value
Age (years) 64.6 (±10.3) 60.3 (±7.5) 0.66
Male, n (%) 22 (73.4%) 27 (90%) 0.09
Female, n (%) 8 (26.6%) 3 (10%)  
Weight (kg) 76 (±11.8) 76.4 (±12.7) 0.89
Height (cm) 166 (±9.0) 169 (±6.1) 0.20
Body mass index (kg/m2) 27.3 (±4.3) 26.6 (±3.3) 0.44
DM alone, n (%) 2 (6.6%) 3 (10 %) 0.57
HT alone, n (%) 5 (16.6%) 5 (16.6%) 0.70
DM + HT, n (%) 10 (33.3%) 11 (36.6%) 0.95
Smoking, n (%) 10 (33.3%) 12 (%40) 0.54
COPD, n (%) 3 (10 %) 4 (13.3%) 0.62
Hyperthyroidism 3 (10 %) 4 (13.3%) 0.76

COPD=chronic pulmonary obstructive disease; DM=diabetes mellitus; HT=hypertension

→Values are expressed as mean (standard deviation) or n (%).